IRCT2016031427042N1
Completed
Phase 2
A clinical trial to compare the effects of heparin with enoxaparin in patients undergoing cesarean section
Vice chancellor for research, Kerman University of Medical Sciences0 sites176 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- caesarean section.
- Sponsor
- Vice chancellor for research, Kerman University of Medical Sciences
- Enrollment
- 176
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The ones who have two of these criteria: age over 35, BMI more than 30, multiparty, preeclampsia, postpartum hemorrhage, emergency cesarean and hysterectomy.
- •Exclusion criteria: patient's discontent, risk of wound infection (diabetes, Chorioamnionitis and long\-lasting rupture of the amniotic sac)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A randomised clinical trial on heparin versus saline solution (NaCl 0,9%) in the maintenance of peripherical venous catheters - NDEUCTR2007-001347-21-ITOSPEDALE POLICLINICO S. MATTEO
Not yet recruiting
Phase 1
A trial to assess the safety of nebulised heparin for acute lung injuryAcute lung injuryRespiratory - Other injuries and accidentsACTRN12606000388516St Vincents Health Melboune20
Completed
Not Applicable
A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)Colon polypJPRN-UMIN000021947ational Hospital Organization160
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
Completed
Phase 2
Heparin In Total Parenteral NutritioCentral venous catheter complications, in particular nosocomial central line associated infections.Infection - Studies of infection and infectious agentsACTRN12605000579695Dr Pita Birch200